This experiment was undertaken for three purposes:
INTRODUCTION

MATERIA1S AND METHODS
To clarify the dose-response ofacute steroid inhibition of wound contraction in the rat, 34 male, albino rats, averaging 300 g, were divided into eight groups and maintained on rat chow and water according to University ofWashington animal care guidelines. The Growth factors derived from platelets have been shown to be important mediators in wound healing processes. Platelet-derived growth factor (PDGF), in particular, exhibits potent chemotactic activity for monocytes, fibroblasts, and smooth muscle cells and accelerates the healing and increases the breaking strength oí linear wounds in rats [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] .
Monocytes and fibroblasts are necessary for normal wound contraction to occur and the number of these cells in wounds and wound contraction is diminished by steroids [17] [18] [19] [20] [21] [22] . Since PDGF is chemotactic for monocytes and fibroblasts and since the absence of monocytes and fibroblasts impairs wound contraction, PDGF may augment wound contraction in acutely steroid-impaired animals. In fact, we have previously reported in a preliminary study that PDGF did augment wound contraction in the acutely steroid-impaired rat but the observed effect was minimal [23] . On the contrary, Pierce et al. [24] have reported that, in steroidtreated animals, PDGF will not reverse the effect of steroids on wound breaking strength, does not attract monocytes into the wound, and does not increase synthesis oí type I procollagen. Increased numbers of fibroblasts were observed, however. Pierce et al. [25] have algo reported that PDGF depresses the number ofmyofibroblasts in excisional wounds. Neither ofthese articles actually studied wound contraction. In fact, we could only find two articles in which the effect ofPDGF on wound contraction was evaluated and the authors reported no effect in normal animal s [26] and the diabetic mouse [10] . So the effect of PDGF on wound contraction remains unclear. Furthermore, we could not find in the literature a dose-response curve of the effect of steroids on wound contraction, which is essential to studies such as these since oversuppression can mask the effects oí the growth factors.
We undertook the following experiments to (1) establish the dose-response curve ofacute steroid inhibition of wound contraction in the rat; (2) confirm the results of our preliminary study ofthe effect ofPDGF on wound contraction in acutely steroid-impaired rats; and (3) to examine the histology ofthe PDGF-treated wounds. animals were given daily methylprednisolone doses of 0.0, OA, 0.8, 1.2, 1.6, 2.0, 3.0, and 4.0 mg. The primary investigator was blinded to the steroid dose. Daily intramuscular injections of steroids were given for 5 days prior to wounding and for the remainder ofthe experimento On Day 5, according to the previously described model, a circular, 4-cm diameter wound was made on the dorsum of each rat [27] . AlI wounds were dressed with Adaptic, 4 X 4 gauze and Tubigrip. The rats were anesthetized daily with halothane for the next 12 days to change dressings, measure wounds, inject steroids, and obtain photos. Three acetate tracings of each wound were made daily. The areas of the daily tracings were determined by computer graphics. The means were calculated, expressed as a fraction of the original mean wound area, and plotted versus time. The areas under the curves were compared using Student's t test, with P < 0.05 considered significant, as described in Part II [23] .
In an effort to confirm our preliminary, 100 male Sprague-Dawley rats, averaging 300 g each, were divided into five groups of 20 rats per group. Each !at was treated as described above and received 2.0 mg methylprednisolone daily or the equivalent dose of hydrocortisone (10 mg) beginning 5 days prior to wounding. In addition, recombinant, human PDGF (,8-chain homodimer (rPDGF-BB), provided by ZymoGenetics, Inc., Seattle, W A) [28] in doses of O, 3, 5, 10, and 15 J.lg was applied daily for 12 days, beginning the day of wounding. The upper dose was chosen to be five times our previous doses, at the upper level of clinical relevance, and similar to the doses of Greenhalgh [10] . The vehicle consisted of phosphate-buffered saline and 5% polyethyleneglycol 8000 (Fisher Scientific, 711 Forbes Avenue, Pittsburgh, PA 15219), which is known to have no effect on the activity ofPDGF. The investigator was blinded to the dose and arder of application and both were randomized. PDGF concentrations were established by amino acid analysis and measurement of mitogenic activity.
To qualitatively evaluate the histology of the wounds, 4-mm punch biopsies were obtained from the center of the wound of 2 rats per group on Days 4 and 8. On Day 12 the entire wound was excised and submitted for H&E and trichrom~ histology. The histologists were blinded to the concentrations ofrPDGF-BB and the steroid dose. Each specimen was qualitatively scored on wound thickness, vascularity, cellularity, collagen content, epithelial migration, and granulation tissue maturity as previously described [10] . further impair contraction. Figure 2A shows the fraction of the original wound area remaining ayer time for subjects that received 0.4, 0.8, and 1.2 mg steroid compared to contraIgo Only a mínimal effect is evident, and these findings are not statistically significant. In contrast, Fig. 2B compares doses of 2.0, 3.0, and 4.0 mg to controls and reveals a statistically significant impairment of wound contraction during the first 4 days after wounding. The subsequent rate of contraction parallels the control group but the total amount of contraction in the impaired subjects remains less than controls at the end of the experimento
In the experiment designed to confirm our preliminary finding that PDGF improved.wound contraction in steroid-impaired rats, data from 80 animal s were available for analysis. Twenty rats died intraoperatively, presumably from anesthetic overdose. The surviving rats appeared healthy, maintained their weights, and took food and water well. The surviving rats were given O, 3, 5, 10, and 15 J1,g/ml rPDGF-BB and numbered 17, 14, 18, 16, and 15 rats per group, respectively. The mean wound fraction open was plotted versus time, beginning on the day ofwounding. The curves are shown in Fig. 3 . The curves for the different doses of PDGF are essentially identical. The slopes of the curves show that wound closure occurred at the same rate in each group. When the curves were integrated and the mean area under the curves compared for each of the PDGF groups, no difference was found in the amount of wound contraction in the various treatment groups.
The H&E and trichrome histology ofthe final wounds at Day 12 was similar for all groups. For each dose of rPDGF-BB, the wounds all appeared very similar in the patterns of cellularity, granulation tissue maturity, and collagen contento Only a modest amount of epithelial migration was evident.
RESULTS
In the steroid, dose-response experiment, all rats survived. Figure 1 shows that significant impairment of wound contraction occurred with daily methylprednisolone doses of 2.0 mg and that higher doses did not analysis of the effects of various growth factors on restoration of wound healing, the dose-response curve for the rat model of wound contraction has not been established. lt is important to establish optimal suppression levels to better understand the effect oftherapies in wound contraction. Oversuppression of wound healing can render the animal unable to respond to injury [24] . From this study, the threshold and optimum dose of methylprednisolone suppression of wound contraction in rats appears to be 2 mg/wound or 6.7 mg/kg given daily as described. This may, in fact, be the most important contribution of tms work since these data were previously unavailable.
The results in our earlier study that suggested rPDGF -BB accelerated wound contraction in a steroidimpaired rat were not reproduced in tms study. Rather than a dose-response curve, we found no improvement in the amount or rate of contraction in the wounds using various amounts of rPDGF-BB ranging from O to even 15 jLg. As mentioned earlier, we attempted to compare our results to others in the literature. But we could find no other studies ofthe effect ofPDGF on wound contraction in steroid-impaired animals. The literature does confirm, however, that PDGF has little effect on reversing the effect of steroids on wound breaking strength [24] . There are two possible explanations for our failure to confirm our earlier reporto lt is possible that rPDGF-BB does have an effect on wound contraction in steroid-impaired rats but that the effect is minimal and therefore difficult to reproduce with small experiments. A more likely explanation, however, is that PDGF in reasonable doses does not have an effect on wound contraction in acutely steroid-impaired animals and that our first observation was by chance alone. 
